Among Patients With Myeloma Undergoing Chemo, High Exercise Compliance Linked With Reduced Fatigue
the ONA take:
Among patients with multiple myeloma, high compliance with exercise was associated with improvements in fatigue, according to a study published in the October 2015 issue of the journal Supportive Care in Cancer.
Because exercise is considered beneficial and safe in patients with multiple myeloma, which is commonly associated with osteolytic bone disease and anemia, resulting in skeletal fragility, persistent fatigue, pain, and reduced quality of life, researchers at the Jewish General Hospital in Montreal, Canada, sought to evaluate the extent of exercise compliance in this patient population.
For the retrospective study, researchers analyzed data from 41 patients with multiple myeloma who participated in a hospital-based rehabilitation program while undergoing chemotherapy. Results showed that exercise compliance was 71% at follow-up and was associated with a decrease in fatigue severity scores.
Researchers found that participants with a history of pathological fracture, spinal cord compression, or radiation were at an increased risk for noncompliance and may therefore require additional supervision to improve exercise compliance.
Among patients with multiple myeloma, high compliance with exercise was associated with improvements in fatigue.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|